Institutional Ownership Kal Vista Pharmaceuticals, Inc. (KALV)
This table provides information about the institutional ownership of Kal Vista Pharmaceuticals, Inc. (KALV). We have compiled data on the 139 institutions that hold shares in the stock, with a total of 54.4 Million shares, which have been reported (via 13F filing form) to have a value of $866 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vr Adviser, LLC
New York, NY |
May 15, 2025 Q1 2025 |
6,703,985
shares
|
$107 Million
18.68% of portfolio
|
Q1 2025
Added 7.27%
|
|
|
Tang Capital Management LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
4,941,798
shares
|
$78.7 Million
3.7% of portfolio
|
Q1 2025
Added 0.98%
|
|
|
Suvretta Capital Management, LLC
New York, NY |
May 15, 2025 Q1 2025 |
4,913,012
shares
|
$78.2 Million
2.48% of portfolio
|
Q4 2024
Added 16.64%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
4,887,867
shares
|
$77.8 Million
3.55% of portfolio
|
Q4 2024
Added 32.54%
|
|
|
Vestal Point Capital, LP
New York, NY |
May 15, 2025 Q1 2025 |
4,751,292
shares
|
$75.6 Million
3.92% of portfolio
|
Q1 2025
Reduced 0.39%
|
|
|
Capital World Investors
Los Angeles, CA |
May 12, 2025 Q1 2025 |
3,177,587
shares
|
$50.6 Million
0.01% of portfolio
|
Q1 2025
Reduced 5.82%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,945,116
shares
|
$46.9 Million
0.0% of portfolio
|
Q2 2024
Added 21.09%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
2,298,598
shares
|
$36.6 Million
0.0% of portfolio
|
Q1 2025
Added 1.92%
|
|
|
Silverarc Capital Management, LLC
|
May 14, 2025 Q1 2025 |
1,698,984
shares
|
$27 Million
4.78% of portfolio
|
Q1 2025
Added 177.53%
|
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
1,617,469
shares
|
$25.8 Million
0.13% of portfolio
|
Q1 2025
Added 25.54%
|
|
|
Octagon Capital Advisors LP
New York, NY |
May 16, 2025 Q1 2025 |
1,370,000
shares
|
$21.8 Million
5.26% of portfolio
|
Q1 2025
Added 22.87%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
1,093,643
shares
|
$17.4 Million
0.0% of portfolio
|
Q1 2025
Reduced 21.37%
|
|
|
Great Point Partners LLC
Greenwich, CT |
May 15, 2025 Q1 2025 |
1,014,367
shares
|
$16.1 Million
7.24% of portfolio
|
Q1 2025
Reduced 43.24%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
915,241
shares
|
$14.6 Million
0.0% of portfolio
|
Q1 2025
Added 11.3%
|
|
|
Emerald Advisers, LLC
|
May 01, 2025 Q1 2025 |
898,190
shares
|
$14.3 Million
0.51% of portfolio
|
Q1 2025
Added 7.43%
|
|
|
Schroder Investment Management Group
London, X0 |
May 13, 2025 Q1 2025 |
868,011
shares
|
$13.8 Million
0.01% of portfolio
|
Q1 2025
Added 7.77%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
May 15, 2025 Q1 2025 |
753,752
shares
|
$12 Million
1.13% of portfolio
|
Q1 2025
New holding
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
May 15, 2025 Q1 2025 |
752,359
shares
|
$12 Million
2.62% of portfolio
|
Q1 2025
Reduced 7.31%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
645,993
shares
|
$10.3 Million
0.0% of portfolio
|
Q1 2025
Reduced 7.19%
|
|
|
Emerald Mutual Fund Advisers Trust
|
May 01, 2025 Q1 2025 |
608,213
shares
|
$9.68 Million
0.57% of portfolio
|
Q1 2025
Added 10.65%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
581,746
shares
|
$9.26 Million
0.04% of portfolio
|
Q1 2025
New holding
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
507,703
shares
|
$8.08 Million
0.0% of portfolio
|
Q1 2025
Added 35.52%
|
|
|
Allostery Investments LP
Stamford, CT |
May 15, 2025 Q1 2025 |
458,302
shares
|
$7.3 Million
7.63% of portfolio
|
Q1 2025
Reduced 4.34%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
402,504
shares
|
$6.41 Million
0.0% of portfolio
|
Q1 2025
Added 1793.25%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
387,562
shares
|
$6.17 Million
0.0% of portfolio
|
Q1 2025
Added 5.84%
|